| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,069 |
5,599 |
$457K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,588 |
2,432 |
$137K |
| 36415 |
Collection of venous blood by venipuncture |
5,507 |
5,035 |
$19K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
172 |
168 |
$13K |
| 99215 |
Prolong outpt/office vis |
72 |
70 |
$9K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
245 |
242 |
$6K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
513 |
497 |
$6K |
| 90686 |
|
618 |
605 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
563 |
554 |
$5K |
| 80061 |
Lipid panel |
341 |
335 |
$4K |
| 84443 |
Thyroid stimulating hormone (TSH) |
251 |
246 |
$4K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
157 |
153 |
$4K |
| 85027 |
|
537 |
517 |
$3K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
746 |
730 |
$2K |
| 59025 |
Fetal non-stress test |
61 |
50 |
$1K |
| 80053 |
Comprehensive metabolic panel |
150 |
148 |
$1K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
43 |
40 |
$1K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
137 |
134 |
$1K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
12 |
12 |
$1K |
| 92551 |
|
179 |
171 |
$974.34 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
12 |
12 |
$903.45 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
29 |
27 |
$876.89 |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
29 |
26 |
$711.09 |
| 87481 |
|
13 |
13 |
$500.78 |
| 0064A |
|
13 |
13 |
$470.61 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
12 |
12 |
$462.18 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
12 |
12 |
$447.27 |
| 99459 |
|
28 |
28 |
$444.29 |
| 0012A |
|
27 |
27 |
$394.86 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
15 |
14 |
$394.03 |
| 99188 |
|
57 |
57 |
$381.14 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
36 |
36 |
$298.77 |
| 99173 |
|
174 |
168 |
$196.50 |
| 86780 |
|
13 |
12 |
$166.37 |
| 82728 |
|
13 |
13 |
$165.60 |
| 81025 |
|
13 |
12 |
$117.22 |
| 96127 |
|
12 |
12 |
$45.91 |
| 85018 |
|
13 |
13 |
$28.75 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
47 |
41 |
$0.00 |
| X5622 |
|
161 |
155 |
$0.00 |